Skip to Main Content

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot?

Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?

And here is our regular feature in which we highlight a different person each week. This time around, we note that Eli Lilly hired Dr. Levi Garraway as senior vice president, global development & medical affairs for the oncology business, succeeding Dr. Richard Gaynor, who is retiring. Currently, Garraway is associate professor of medicine in the Department of Medical Oncology at the Dana-Farber Cancer Institute and Harvard Medical School, and an associate physician at the Brigham and Women’s Hospital.


Karyopharm Therapeutics hired Dr. Humphrey Gardner as senior vice president, clinical development;

pSivida hired Nancy Lurker as chief executive officer and president;


Moderna Therapeutics hired Melissa Moore as chief scientific officer;

eFFECTOR Therapeutics hired Dr. Jeremy Barton as chief medical officer;

ClearLight Diagnostics hired Laurie Goodman as chief scientific officer;

C4 Therapeutics promoted Andy Phillips to president and chief scientific officer;

OSE Immunotherapeutics hired Iris Pauporte as clinical project director;

Ocera Therapeutics hired Akiko Shibata as head of business development;

Aptevo Therapeutics hired Randy Maddux as senior vice president, operations;

Alpine Immune Sciences hired Dr. Stanford Peng as executive vice president and chief medical officer;

PsiOxus Therapeutics hired Dr. Charles Morris as chief development officer;

PsiOxus Therapeutics hired Karen LaRochelle as chief business officer;

PsiOxus Therapeutics named Dr. Brian Champion as chief scientific officer;

PsiOxus Therapeutis said Theodora Harold is stepping down as chief financial officer;

Eurofins Bioanalytical Services hired Jennifer Ohayon as a scientific director for large molecule bioanalysis.